H.I.G. Capital — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Alder BiopharmaceuticalsJan 2018

BiotechBothell, US

Randall Schatzman(Executive Officer, Director)James Bucher(Executive Officer)Clay Siegall(Director)Jeffrey Smith(Executive Officer)Paul Carter(Director)Randal Hassler(Executive Officer)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.